Regenerative Medicine has the potential to heal or replace tissues and organs damaged by age, disease, or trauma, as well as to normalize congenital defects. Since the inception of the field several decades ago, a number of regenerative medicine therapies, including those designed for wound healing and orthopedic applications, have received Food and Drug Administration (FDA) approval/clearance and are now commercially available. The delivery of therapeutic cells that directly contribute to the structure and function of new tissues is a principle paradigm of regenerative medicine to date. The cells used in these therapies are either autologous or allogeneic. Autologous uses a person’s own stem cells and allogeneic uses cells from a donor.
At Anodyne of Jacksonville, we specialize in Allogeneic Cell Therapy.
Allogeneic Cell Therapy, also known as Regenerative Cell Therapy, is an area of healthcare that has the potential to have a disruptive effect on the way certain human ailments and conditions are treated. Allogeneic cell and tissue allografts are able to supplement the body’s natural healing process.
Allogeneic Cell Therapy uses a cell and tissue allograft that is comprised of growth factors, cytokines, proteins, and mesenchymal stem cells to prevent and treat health conditions, disease and chronic pain. We utilize this type of Regenerative Cell Therapy in our clinic because we have found through research and our actual patient outcomes that it is more effective on joint and ligament conditions and/or deterioration as opposed to autologous stem cell therapies utilizing adipose tissue (fat) or bone marrow. We also prefer this method of Regenerative Cell Therapy because it is far less invasive on the patient.
As our bodies age we experience longer healing times, inflammation, and cell exhaustion (cell aging). Over time, healthy tissue can become dysfunctional, not only due to age, but injury as well. We administer our cell and tissue allograft to the recipient’s area of injury or degeneration such as the knee, neck, spine, or shoulder to help repair, reconstruct, replace, or supplement the same basic functions of the recipient’s cells or tissues.
The procedure takes less than 15 minutes with minimal pain and is extremely safe and effective.
The human body utilizes a variety of tissue and cell interactions to support the healing process. Our cell and tissue allografts supplement similar tissue in your body via scaffolding, growth factors, homeostatic and general cytokines.
10-year NFL veteran, 8-year Jacksonville Jaguar and two-time Pro Bowler “Big” John Henderson received regenerative cell therapy in his back and both knees. His results have been phenomenal – Big John was able to avoid surgery and get rid of his wheelchair!
Patients with bone, joint, and ligament conditions/injuries including:
• Back Pain • Facet Syndrome • Degenerative Disc Disease • Lumbar Arthritis • Osteoarthritis • Bursitis • Cervical Pain • Cervical DJD • Cervical Arthritis • Carpal Tunnel Syndrome • Wrist Arthritis • Tennis Elbow • Golfer’s Elbow • Bicep Tendon Tear • Shoulder Degeneration and Arthritis • Shoulder Injuries • Rotator Cuff Tears • Hip Pain • Labrum Tear • Hip Osteoarthritis • Hip Degeneration • Hip Bursitis • Meniscus Tear • Knee Degeneration • ACL or PCL Injury • Chondromalacia • Foot Pain • Plantar Fasciitis
The cell and tissue allograft we use are processed in an FDA registered lab. The cell and tissue allograft we use is minimally manipulated and prepared utilizing proprietary extraction methods that reduce the loss of important cytokines, growth factors, proteins, and biomolecules, and are intended for homologous use.
The cell and tissue allograft we use is processed from donated human tissue from full term deliveries. Comprehensive medical and social histories of the donors are obtained and tissues are procured, processed, and tested in accordance with standards established by FDA requirements to minimize potential risks of disease transmission to recipients. Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.